Search Results

Showing results 411 - 420 for weill cornell connect patient portal

For Providers | Weill Cornell Imaging at NewYork-Presbyterian

...Weill Cornell Medicine NewYork - Presbyterian © Weill Cornell Medicine....

https://wcinyp.org/providers

Enterprise Innovation | Weill Cornell Medicine

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/

EmulatRx: A Multi-Agent System for Intelligent Clinical Trial Design | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/emulatrx-multi-agent-system-intelligent-clinical

Opto-Opioids: Light-Activated Compounds for Locally-restricted and Reversible Pain Management | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/opto-opioids-light-activated-compounds-locally

Platform for Aptamer-Mediated Cellular Regulation using Circular RNA Nanodevices | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/platform-aptamer-mediated-cellular-regulation-using

Engineered C' Dots Restore Tumor Microenvironment Homeostasis to Enable Effective Cancer Immunotherapy | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/engineered-c-dots-restore-tumor-microenvironment

The Winding Road from Bench to FDA Approval for First Mitochondria-Targeting Drug | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/news-events/winding-road-bench-fda-approval-first-mitochondria-targeting-drug

NSF I-Corps Virtual Courses (Upcoming Application Deadline: 3/18/26) | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/events/nsf-i-corps-virtual-courses-upcoming-application-deadline-31826

Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by

...Connect Departments Alumni News Events Weill Cornell Medicine....

https://geneticmedicine.weill.cornell.edu/publications/strategies-aerosol-therapy-alpha-1-antitrypsin-deficiency-aerosol-route

Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic

...Connect Departments Alumni News Events Weill Cornell Medicine....

https://geneticmedicine.weill.cornell.edu/publications/synthesis-e-coli-alpha-1-antitrypsin-variants-therapeutic-potential-emphysema-and-thrombosis

Showing results 411 - 420 for weill cornell connect patient portal